Researchers at University of Chicago have designed synthetic proteins that can only interact with a pre-determined partner and have identified that a single protein interaction is key for regulating the ability of embryonic stem cells to change into other cell types, a new study published in the journal Molecular Cell reveals.
"Our work suggests that the apparent complexity of protein networks is deceiving, and that a circuit involving a small number of proteins might control each cellular function," said senior author Shohei Koide, PhD, professor of biochemistry & molecular biophysics at the University of Chicago.
For a cell to perform biological functions and respond to the environment, proteins must interact with one another in immensely complex networks, which when diagrammed can resemble a subway map out of a nightmare. These networks have traditionally been studied by removing a protein of interest through genetic engineering and observing whether the removal destroys the function of interest or not. However, this does not provide information on the importance of specific protein-to-protein interactions.
"The name, 'directed network wiring,' comes from the fact that we create minimalist networks," Koide said. "We first remove all communication lines associated with a protein of interest and add back a single line. It is analysis by addition."
Despite the complexity of the protein network associated with stem cell development, the team discovered that restoring only one interaction—between Grb2 and a protein known as Ptpn11/Shp2 phosphatase—was enough to allow stem cells to again change into other cell types.
"We were really surprised to find that consolidating many interactions down to a single particular connection for the protein was sufficient to support development of the cells to the next stage, which involves many complicated processes," Koide said. "Our results show that signals travel discrete and simple routes in the cell."
Koide and his team are now working on streamlining directed network wiring and applying it to other areas of study such as cancer. With the ability to dramatically simplify how scientists study protein interaction networks, they hope to open the door to new research areas and therapeutic approaches.
"We can now design synthetic proteins that are far more sophisticated than natural ones, and use such super-performance proteins toward advancing science and medicine," he said.